Clinical use of telomere lenghth in idiopathic pulmonary fibrosis

被引：0
|
作者：
Muca, Trejsi [1 ]
Van Dievoet, Marie-Astrid [2 ]
Decottignies, Anabelle [3 ]
Froidure, Antoine [1 ]
机构：
[1] UCLouvain, Clin Univ St Luc, Pulm Dept, Brussels, Belgium
[2] UCLouvain, Clin Univ St Luc, Hematol Dept Lab Med, Brussels, Belgium
[3] UCLouvain, Telomeres Res Grp, Genet & Epigenet Alterat Genomes, De Duve Inst, Brussels, Belgium
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA1715
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: A clue to telomere involvement
    Carulli, Lucia
    Dei Cas, Alessandra
    Nascimbeni, Fabio
    HEPATOLOGY, 2012, 56 (05) : 2001 - 2003
  • [42] Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis
    Kelich, Joseph
    Aramburu, Tomas
    van der Vis, Joanne J.
    Showe, Louise
    Kossenkov, Andrew
    van der Smagt, Jasper
    Massink, Maarten
    Schoemaker, Angela
    Hennekam, Eric
    Veltkamp, Marcel
    van Moorsel, Coline H. M.
    Skordalakes, Emmanuel
    JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 219 (05):
  • [43] PULMONARY HYPERTENSION IN IDIOPATHIC PULMONARY FIBROSIS: PREVALENCE AND CLINICAL PROGRESS
    Castria, D.
    Refini, R. M.
    Bargagli, E.
    Mezzasalma, F.
    Pierli, C.
    Rottoli, P.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2012, 25 (03) : 681 - 689
  • [44] Pulmonary hypertension in idiopathic pulmonary fibrosis: Epidemiology and clinical correlates
    Shorr, AF
    Cors, C
    Lettieri, CJ
    Helman, DL
    Nathan, SD
    CHEST, 2005, 128 (04) : 218S - 218S
  • [45] 2022 update on clinical practice guidelines for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Tzilas, Vasilios
    Tzouvelekis, Argyrios
    Ryu, Jay H.
    Bouros, Demosthenes
    LANCET RESPIRATORY MEDICINE, 2022, 10 (08): : 729 - 731
  • [46] Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study
    Duckworth, Anna
    Gibbons, Michael A.
    Allen, Richard J.
    Almond, Howard
    Beaumont, Robin N.
    Wood, Andrew R.
    Lunnon, Katie
    Lindsay, Mark A.
    Wain, Louise, V
    Tyrrell, Jess
    Scotton, Chris J.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (03): : 285 - 294
  • [47] Pirfenidone: a guide to its use in idiopathic pulmonary fibrosis
    Gillian M. Keating
    Katherine A. Lyseng-Williamson
    Natalie J. Carter
    Drugs & Therapy Perspectives, 2012, 28 (7) : 10 - 13
  • [48] Potential role of statin use in idiopathic pulmonary fibrosis
    Santana, Alfredo N. C.
    Kairalla, Ronaldo A.
    Carvalho, Carlos R. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (09) : 1048 - 1048
  • [49] Nintedanib in idiopathic pulmonary fibrosis: a guide to its use
    Keating G.M.
    Drugs & Therapy Perspectives, 2015, 31 (10) : 329 - 333
  • [50] Clinical and pathological aspects of idiopathic pulmonary fibrosis in cats
    Cony, Fernanda G.
    Argenta, Fernando F.
    Heck, Lilian C.
    Moreira, Leticia F.
    Costa, Fernanda V. A.
    Sonne, Luciana
    Pavarini, Saulo P.
    PESQUISA VETERINARIA BRASILEIRA, 2019, 39 (02): : 134 - 141
12345